Advancing Pathology for Cancer Diagnosis, Staging and Prognosis 2018 covers topics such as:
- Overcoming Mechanisms of Therapeutic Resistance in Advanced Castration Resistant Prostate Cancer
- Current status of minimally invasive diagnosis and staging of lung malignancies
- Breast Cancer, Chemo-resistance and ErbB receptors
- ErbB-targeted CAR T-cell immunotherapy of cancer: a strategy to maximize the window of therapeutic opportunity
Advancing Pathology for Cancer Diagnosis, Staging and Prognosis 2018 brings together: academics, clinicians and industrial partners.